Trb Chemedica International Sa
Clinical trials sponsored by Trb Chemedica International Sa, explained in plain language.
-
New eye drop could match current treatment for dry eye relief
Symptom relief Recruiting nowThis study tests whether a new eye drop (BUFY02) works as well as an existing one (TRB02) for treating dry eye disease. About 80 people with dry eye for at least 3 months will use the drops daily for 3 months. Researchers will check eye health and symptoms to see if both treatmen…
Phase: NA • Sponsor: TRB Chemedica International SA • Aim: Symptom relief
Last updated May 26, 2026 11:49 UTC
-
New eye drop BUFY01 takes on SVS20 in dry eye showdown
Symptom relief Recruiting nowThis study tests if a new eye drop, BUFY01, works as well as an existing one, SVS20, for treating dry eye disease. About 80 adults with dry eyes will use one of the two drops daily for three months. Researchers will check eye health and symptoms to see if both treatments provide …
Phase: NA • Sponsor: TRB Chemedica International SA • Aim: Symptom relief
Last updated May 26, 2026 11:29 UTC